Evidence map›Paper›PMID 40981676›Full record

ArticleBiology of reproduction2025

An improved vitrification protocol for the fast and safe storage of mouse oocytes†.

Tina Hodgson, Hollie Lane, Helen Horsler, Juliette Horwood, Laura Denti, Fabio Delaqua, Katharine Crawley, Benjamin Davies

Abstract read
In one paragraph

Article in Biology of reproduction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tina HodgsonThe Genetic Modification Service, The Francis Crick Institute, London, UK.
Hollie LaneThe Genetic Modification Service, The Francis Crick Institute, London, UK.
Helen HorslerThe Genetic Modification Service, The Francis Crick Institute, London, UK.
Juliette HorwoodThe Genetic Modification Service, The Francis Crick Institute, London, UK.
Laura DentiThe Genetic Modification Service, The Francis Crick Institute, London, UK.
Fabio DelaquaThe Genetic Modification Service, The Francis Crick Institute, London, UK.
Katharine CrawleyThe Genetic Modification Service, The Francis Crick Institute, London, UK.
Benjamin DaviesThe Genetic Modification Service, The Francis Crick Institute, London, UK.ORCID 0000-0003-3623-600X

Funding

Cancer Research UK CC1111Francis Crick InstituteUK Medical Research Council CC1111Wellcome TrustWellcome Trust CC1111
6 · The paper itself

Abstract

Cryopreservation methods for archiving and distributing mouse strains mostly focus on freezing embryos or sperm. Although protocols for the cryopreservation of wild-type mouse oocytes are available, these methods have not been widely adopted in large biomedical research facilities. This is partly due to a lack of validation of the available methods on a large scale using a range of genetically modified oocytes. Furthermore, some of the existing methods report a relatively low rate of fertilization, requiring either the zona pellucida to be physically breached or the inclusion of cumulus cells to enable efficient fertilization, interventions which might be incompatible with maintaining hygiene barriers. Existing methods also often use cryovials rather than straws or slimline vitrification devices, which are more practical for storage and handling. Here, we present a robust vitrification protocol for large-scale oocyte cryopreservation, achieving high viability and fertilization rates comparable to fresh oocytes. We have extensively tested the protocol for in vitro fertilization of many genetically altered strains, using both genetically altered and wild-type C57BL/6J oocytes and sperm. Providing an archive of cryopreserved oocytes harboring genetically modified alleles separately from archives of cryopreserved sperm allows multiple allele combinations to be generated during the rederivation process. This reduces subsequent breeding steps and the need to maintain live stocks of mice. Furthermore, cryopreserving oocytes for later use enables them to be obtained from females at the optimal age, thereby reducing the number of mice required and providing greater scheduling flexibility for subsequent genetic modification and rederivation work.

Indexed as

CryopreservationOocytesVitrificationAnimalsFemaleFertilization in VitroMaleMiceMice, Inbred C57BLcryopreservationin vitro fertilizationoocytesrederivationvitrification

Identifiers

PMID40981676
PMCPMC12706468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.